Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
TBI Dose De-escalation for Fanconi Anemia
This study is currently recruiting participants.
Study NCT00352976 Information provided by Masonic Cancer Center, University of Minnesota
First Received: July 14, 2006 Last Updated: October 1, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fanconi Anemia
Additional conditions recognized in this trial
Anemia
More general conditions related to this trial
Anemia, Aplastic
Anemia, Hypoplastic, Congenital
Bone Marrow Diseases
DNA Repair-Deficiency Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Metabolic Diseases
Interventions listed in this trial
Cyclophosphamide
Fludarabine
anti-thymocyte globulin (ATG)
Total Body Irradiation
Bone Marrow Transplantation
Additional drug interventions recognized in this trial
Antilymphocyte Serum
Fludarabine monophosphate
More general drug interventions related to this trial
Alkylating Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Masonic Cancer Center, University of Minnesota
Back to top of Main Content
